These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

667 related items for PubMed ID: 23842846

  • 21. Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
    Mirzada N, Ladenvall P, Hansson PO, Eriksson P, Dellborg M.
    Int J Cardiol; 2015 Sep 15; 195():293-9. PubMed ID: 26056962
    [Abstract] [Full Text] [Related]

  • 22. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M, Mullen M.
    Catheter Cardiovasc Interv; 2015 May 15; 85(6):1058-65. PubMed ID: 25413379
    [Abstract] [Full Text] [Related]

  • 23. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
    Gevorgyan Fleming R, Kumar P, West B, Noureddin N, Rusheen J, Aboulhosn J, Tobis JM.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):365-372. PubMed ID: 31654558
    [Abstract] [Full Text] [Related]

  • 24. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH, Bertog SC, Momberger J, Franke J, Hofmann I, Renkhoff K, Joy S, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Jun 15; 85(7):1262-7. PubMed ID: 24948394
    [Abstract] [Full Text] [Related]

  • 25. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B.
    Heart; 2008 Mar 15; 94(3):336-41. PubMed ID: 17639093
    [Abstract] [Full Text] [Related]

  • 26. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun 15; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 27. Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome.
    Post MC, Van Deyk K, Budts W.
    Acta Cardiol; 2005 Oct 15; 60(5):515-9. PubMed ID: 16261783
    [Abstract] [Full Text] [Related]

  • 28. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
    Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.
    Catheter Cardiovasc Interv; 2017 Jan 15; 89(1):124-133. PubMed ID: 27027873
    [Abstract] [Full Text] [Related]

  • 29. Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials.
    Pandit A, Aryal MR, Pandit AA, Jalota L, Kantharajpur S, Hakim FA, Lee HR.
    Heart Lung Circ; 2014 Apr 15; 23(4):303-8. PubMed ID: 24495944
    [Abstract] [Full Text] [Related]

  • 30. Recurrent events after percutaneous closure of patent foramen ovale.
    Wallenborn J, Bertog SC, Franke J, Steinberg DH, Majunke N, Wilson N, Wunderlich N, Sievert H.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):541-6. PubMed ID: 22707325
    [Abstract] [Full Text] [Related]

  • 31. Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.
    Becker M, Frings D, Schröder J, Ocklenburg C, Mühler E, Hoffmann R, Franke A, Lepper W.
    J Interv Cardiol; 2009 Dec 01; 22(6):503-10. PubMed ID: 19821880
    [Abstract] [Full Text] [Related]

  • 32. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K, Gevorgyan R, Mangels D, Masoomi R, Mojadidi MK, Tobis J.
    Catheter Cardiovasc Interv; 2014 Sep 01; 84(3):455-63. PubMed ID: 24550064
    [Abstract] [Full Text] [Related]

  • 33. Very long-term follow-up after percutaneous closure of patent foramen ovale.
    Eeckhout E, Martin S, Delabays A, Michel P, Girod G.
    EuroIntervention; 2015 Apr 01; 10(12):1474-9. PubMed ID: 24429213
    [Abstract] [Full Text] [Related]

  • 34. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, Nedeltchev K, Mattle HP, Windecker S, Meier B.
    Circulation; 2012 Feb 14; 125(6):803-12. PubMed ID: 22238228
    [Abstract] [Full Text] [Related]

  • 35. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
    Davies A, Ekmejian A, Collins N, Bhagwandeen R.
    Heart Lung Circ; 2017 Mar 14; 26(3):246-250. PubMed ID: 27555053
    [Abstract] [Full Text] [Related]

  • 36. A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke.
    Kasner SE, Sondergaard L, Nakum M, Gomez Montero M, Hashim M, Landaas EJ.
    J Med Econ; 2024 Mar 14; 27(1):337-343. PubMed ID: 38373018
    [Abstract] [Full Text] [Related]

  • 37. Results of percutaneous closure of patent foramen ovale with the GORE(®) septal occluder.
    Knerr M, Bertog S, Vaskelyte L, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2014 Jun 01; 83(7):1144-51. PubMed ID: 24323667
    [Abstract] [Full Text] [Related]

  • 38. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.
    Ntaios G, Papavasileiou V, Makaritsis K, Michel P.
    Int J Cardiol; 2013 Oct 30; 169(2):101-5. PubMed ID: 24041984
    [Abstract] [Full Text] [Related]

  • 39. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device.
    Varotto L, Bregolin G, Paccanaro M, De Boni A, Bonanno C, Perini F.
    Cerebrovasc Dis; 2020 Oct 30; 49(2):124-134. PubMed ID: 32289794
    [Abstract] [Full Text] [Related]

  • 40. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
    Scalise F, Auguadro C, Sorropago G, Sorropago A, Novelli E, Finizio M, Specchia G.
    J Interv Cardiol; 2016 Aug 30; 29(4):406-13. PubMed ID: 27338839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.